FCM
Farallon Capital Management Portfolio holdings
AUM
$17.3B
1-Year Est. Return
47.36%
This Fund
S&P 500
1 Year Est. Return
+47.36%
AUM
$17.3B
AUM Growth
-$372M
(-2.1%)
Holding
171
Top Buys
| 1 | +$507M | |
| 2 | +$444M | |
| 3 | +$319M | |
| 4 |
Boston Scientific
BSX
|
+$264M |
| 5 |
KKR & Co
KKR
|
+$251M |
Top Sells
| 1 | +$528M | |
| 2 | +$352M | |
| 3 | +$333M | |
| 4 |
Intuit
INTU
|
+$333M |
| 5 |
K
Kellanova
K
|
+$323M |
Sector Composition
| 1 | Healthcare | 49.65% |
| 2 | Technology | 16.89% |
| 3 | Financials | 13% |
| 4 | Consumer Discretionary | 6% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$19.4B
| $1.16B | 6.7% |
14,582,796
-42,896
|
|
||
2
Microsoft
MSFT
$3.01T
| $1.07B | 6.18% |
2,214,079
+300,944
|
|
||
3
Amazon
AMZN
$2.33T
| $1.04B | 6% |
4,499,894
+994,194
|
|
||
4
Aon
AON
$73.1B
| $941M | 5.43% |
2,665,238
+387,221
|
|
||
5
Natera
NTRA
$28.3B
| $897M | 5.18% |
3,914,366
-339,086
|
|
||
|
6
Boston Scientific
BSX
$107B
| $709M | 4.09% |
7,439,564
+2,693,007
|
|
||
7
Exelixis
EXEL
$10.8B
| $689M | 3.97% |
15,709,500
-3,792,000
|
|
||
8
BridgeBio Pharma
BBIO
$12.5B
| $688M | 3.97% |
8,998,463
+806,463
|
|
||
9
Protagonist Therapeutics
PTGX
$6.05B
| $537M | 3.1% |
6,144,006
-52,000
|
|
||
10
Wabtec
WAB
$44.5B
| $529M | 3.05% |
2,476,003
+270,905
|
|
||
11
UnitedHealth
UNH
$264B
| $528M | 3.05% |
1,598,906
-287,594
|
|
||
|
CYBR
12
DELISTED
CyberArk
CYBR
| $470M | 2.71% |
+1,053,040
|
|
||
13
Walt Disney
DIS
$183B
| $469M | 2.71% |
4,125,991
-1,072,977
|
|
||
14
Synopsys
SNPS
$82.6B
| $469M | 2.71% |
+999,200
|
|
||
15
Thermo Fisher Scientific
TMO
$193B
| $368M | 2.13% |
635,685
-622,556
|
|
||
16
Lantheus
LNTH
$5.23B
| $361M | 2.08% |
5,427,479
+1,950,252
|
|
||
17
Aramark
ARMK
$10.7B
| $345M | 1.99% |
9,357,046
+360,844
|
|
||
18
Salesforce
CRM
$181B
| $334M | 1.93% |
1,261,177
-1,201,133
|
|
||
19
Charles Schwab
SCHW
$171B
| $334M | 1.93% |
3,339,657
+88,000
|
|
||
20
Crinetics Pharmaceuticals
CRNX
$4.05B
| $323M | 1.86% |
6,933,098
+1,163,000
|
|
||
21
Broadcom
AVGO
$1.51T
| $309M | 1.78% |
+892,400
|
|
||
22
Liquidia Corp
LQDA
$2.99B
| $299M | 1.72% |
8,656,038
+90,400
|
|
||
23
Nasdaq
NDAQ
$49.7B
| $290M | 1.68% |
2,989,213
-633,830
|
|
||
24
Beam Therapeutics
BEAM
$2.79B
| $279M | 1.61% |
10,063,111
|
|
||
|
25
KKR & Co
KKR
$83.6B
| $257M | 1.48% |
+2,017,700
|
|